# A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

> **NCT04478994** · PHASE1 · TERMINATED · sponsor: **Amgen** · enrollment: 3 (actual)

## Conditions studied

- Diffuse Cutaneous Systemic Sclerosis

## Interventions

- **BIOLOGICAL:** TEPEZZA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04478994
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-17
- **Primary completion:** 2022-11-29
- **Final completion:** 2022-12-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2024-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04478994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04478994, "A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04478994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*